DAPAGLIFLOZIN

Nanjing King-Pharm Co., Ltd., established in 2009, manufactures active pharmaceutical ingredients, chiral and advanced intermediates, microbial/fermentation reagents, and specialized reagents, alongside outsourcing, custom synthesis, and consultation services. Offering CRO, CMO, and CDMO contract manufacturing under its own brand, with an experienced R&D team and reliable delivery, the company accommodates buyer specifications and small orders, distributing to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.